v3.26.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2025
Share-based Compensation [Abstract]  
Schedule of Binomial Option-Pricing Model Used for the Fair Value Measurement

The following table lists the inputs to the binomial option-pricing model used for the fair value measurement of equity-settled share options for the above Options Plans for the years 2024, 2024 and 2023:

 

   December 31, 
   2025   2024   2023 
             
Dividend yield   0%   
-
%   0%
Expected volatility of the share prices   104%   
-
%   107%
Risk-free interest rate   4.2%   
-
%   4.2%
Expected term (in years)   10    
-
%   10 
Schedule of Number of Options Granted to Employees Under the Option Plans The following table summarizes the number of options granted to employees under the Option Plans for the year ended December 31, 2025 and related information:
   Number of options  

Weighted

average

exercise

price

  

Weighted average remaining contractual term

(in years)

  

Aggregate

intrinsic
value

 
                 
Balance as of December 31, 2024   97,228,400    0.005    8.65    12 
                     
Granted   413,200,000    
-
    10    12 
                     
Forfeited   
-
    
-
    
-
    
-
 
                     
Balance as of December 31, 2025   510,428,400    0.001    9.54    12 
                     
Exercisable as of December 31, 2025   75,600,975    0.001    9.54    12 
Schedule of Company’s Outstanding and Exercisable Options Granted to Employees The following table summarizes information about the Company’s outstanding and exercisable options granted to employees as of December 31, 2025:
Exercise price 

Options outstanding as of

December 31, 2025

  

Weighted average remaining

contractual term
(years)

  

Options exercisable as of December 31,

2025

  

Weighted average remaining

contractual term
(years)

 
$0.001   510,428,400    9.54    75,600,975    9.54 
Schedule of ADSs Restricted Shares Units Activity A summary of ADSs restricted shares units activity for the year ended December 31, 2025 is as follows:
    Number of ADS     Weighted average grant date fair value  
             
Balance as of December 31, 2024     106,183       7.22  
                 
Granted     218,541       0.87  
Vested     (26,974 )     4.31  
Forfeited     (26,679 )     4.10  
                 
Balance as of December 31, 2025     271,071       4.13  
Schedule of Total Share-Based Compensation Expense to Equity-Based Awards The total share-based compensation expense related to all of the Company’s equity-based awards, recognized for the years ended December 31, 2025, 2024 and 2023 is comprised as follows:
  

Year ended
December 31,

 
   2025   2024   2023 
             
Research and development expenses  $(48)  $322   $107 
Cost of revenues   182           
Marketing, general and administrative expenses   170    360    1,032 
Total share-based compensation  $304   $682   $1,139